MEDICAL & HEALTHCARE SERVICES

The Greater Bay Area: Why Co-operation is the Best Medicine

01 April 2020

In its 36 years in Hong Kong, Baxter Healthcare Limited has established itself as a major provider of technologies and treatments, while working with stakeholders in the city’s public and private healthcare systems to help make the SAR an incubator for innovative healthcare thinking. Now the company is preparing for the GBA development, which it believes will improve health outcomes for millions of people across the Pearl River Delta. More

hktdc research

China Deepens Reform of Healthcare Security System

24 March 2020

The State Council recently distributed its Opinions on Deepening the Reform of the Healthcare Security System. More

multimedia

Hong Kong medical 3D printing embraces the Belt and Road

26 February 2020

hktdc research

Hong Kong Companies in the GBA (16): Two-way Medical Referral Services Platform

20 February 2020

Founded in Shenzhen in 2014, the Easyfit Doctors Consortium provides a wide range of disease prevention and overseas medical services. Through its one-stop medical services platform, Easyfit introduces world-leading medical service systems and home healthcare models to the mainland market. Candy Yau, founder and director of Easyfit, spoke to HKTDC Research about her experience in operating medical referral services in the GBA. More

hktdc research

China’s Elderly Market: Servicing Middle-Class Consumers

05 December 2019

A consumer survey conducted by HKTDC Research discovered that mainland senior demand for leisure and entertainment services, while health improvement activities are also popular. The per-capita expenditure on services consumption ranges between RMB50 and RMB250. There is a rapid increase in the demand for tourism services, with group tours designed for seniors probably attracting older consumers the most. More

hktdc research

Proposal to Revise Controlled Substances Regulations Under Consideration

25 October 2019

The U.S. Drug Enforcement Administration is seeking input by 23 December on a proposal to revise its existing regulations that manage the quotas for controlled substances (including fentanyl, oxycodone, hydrocodone, oxymorphone or hydromorphone) as well as list I chemicals ephedrine, pseudoephedrine and phenylpropanolamine held by DEA-registered manufacturers. More

hktdc research

China Introduces Nationwide Random Drug Quality Inspections

26 September 2019

Random spot checks on drug quality are to be introduced across China, with a view to ensuring high standards are adhered to with regard to the production, distribution and administration of all such products. More

hktdc research

China Tightens Up Health Food Labelling Requirements

19 September 2019

New health-food packaging guidelines are set to come into force across the mainland from 1 January next year. These will oblige manufacturers to incorporate prominent messages reminding consumers that such products do not constitute medicines and should not be used in preference to officially-prescribed / sanctioned remedies. More

hktdc research

China Toughens Up Health Food Ingredients Regime

19 September 2019

Under the terms of new measures set to come into force on 1 October this year, all ingredients listed in the Health Food Raw Materials Directory – with the exception of certain specified vitamins / minerals – must comply with the requirements... More

hktdc research

China Issues Comprehensively Updated National Medical Insurance Drug Catalogue

06 September 2019

China has released the first comprehensive update to its National Drug Catalogue for Basic Medical Insurance, Work-Related Injury Insurance and Maternity Insurance since it was first published in 2000. More

Page of 9